Posts Tagged ‘Switzerland’
Geneva Unveils Master Plan To Become An Innovation Hub
The State of Geneva has unveiled an ambitious master plan aimed at transforming the canton into a global innovation hub. In addition to the CHF 10 million already invested annually in the sector, an extra CHF 11 million will be injected over the next three years, until 2027. Unveiled at Campus Biotech by State Councilor…
Read Moreten23 health Opens State-of-the-Art VIVA2® Sterile Manufacturing Facility in Visp
This advanced, energy-efficient plant will enhance the company’s capabilities in commercial and clinical manufacturing of sterile medicines, including vials, syringes, and cartridges. The Swiss CDMO celebrates the grand opening of its VIVA2® facility in Visp. The facility adds two production lines: Line 2, designed for large-scale filling of ready-to-use containers, and Line 3,…
Read MoreNeo Medical completes a $68 million Series B financing round
Neo Medical SA (Neo), a Lausanne-Based technology company specialising in spine surgery, has announced the successful completion of its Series B financing round, including the conversion of existing shareholder loans. With this financing round, Neo has secured an additional equity investment of up to $68 million (CHF 58 million) to accelerate its global growth. …
Read MoreDebiopharm lays the foundation stone for its new building
The new building will have a surface area of 3,500m2 dedicated to the creation of 150 to 300 flexible workstations. It will enable the company to expand and develop. The work will be completed in 2026. The building will also house a reservoir containing a total of 4.5 million litres of water, which…
Read MoreLatsis Prize: Prof. Mackenzie W. Mathis Awarded
Mackenzie W. Mathis, a professor at EPFL and winner of the Latsis 2024 Swiss Science Prize, is a pioneer in the application of artificial intelligence (AI) to behavioural neuroscience. Prof. Mathis research aims to understand the neural bases of learning and movement. She uses mice playing video games while recording their brain activity,…
Read MoreFluoSphera is awarded a CHF 1.1 million grant from Innosuisse
FluoSphera S.A., a biotechnology company developing versatile and disruptive in-vitro solutions for drug discovery to predict drug efficacy and safety under systemic conditions, today announced that its new innovation project together with EPFL and the University of Geneva (UNIGE) has been awarded a grant of CHF 1,100,000 Swiss francs from Innosuisse, the Swiss Innovation Agency.…
Read MoreTimeline raises CHF56 Million and partners with L’Oréal
Already backed by Nestlé, the Swiss Health Valley startup co-founded by former EPFL President Patrick Aebischer, now counts a second leading multinational among its investors: L’Oréal. The fact that L’Oréal is investing in Timeline, a pioneering longevity brand, demonstrates the cosmetics giant’s interest in this fast-growing trend,” says Chris Rinsch, co-founder of the…
Read MoreAlzheimer Research: Gliapharm raises CHF 3.65 Million
The Alzheimer’s Drug Discovery Foundation (ADDF) invests CHF 3.64 Million in GliaPharm to advance its lead programme to accelerate the development of GliaPharm’s new drug, with the aim to gain approval for clinical testing in Alzheimer’s disease. GliaPharm SA, a biotech company that specializes in the research and development of novel therapies to…
Read MoreBioAlps Awards 2023
Dr. Hervé Bourlard receive the BioAlps Academia Award, and Dr. Igor Fish and Dr Nicolas Mermod receive the BioAlps Industry Award.
Read MoreA patient in remission from HIV after a bone marrow transplant
The HUG and the Institut Pasteur have announced an exceptional case of HIV remission. A promising discovery. The patient has been living with HIV since the early 1990s and has always been on antiretroviral treatment. In 2018, to treat a particularly aggressive form of leukaemia, he underwent a stem cell transplant. One month after…
Read More